These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1474933)

  • 1. A simple method for overproduction and purification of p24 Gag protein of human immunodeficiency virus type 1.
    Tanaka N; Saitoh A; Nakata A; Shinagawa H
    Microbiol Immunol; 1992; 36(8):823-31. PubMed ID: 1474933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overproduction, purification, and diagnostic use of the recombinant HIV-1 Gag proteins, the precursor protein p55 and the processed products p17, p24, and p15.
    Saito A; Morimoto M; Ohara T; Takamizawa A; Nakata A; Shinagawa H
    Microbiol Immunol; 1995; 39(7):473-83. PubMed ID: 8569532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression in Escherichia coli and purification of human immunodeficiency virus type 1 capsid protein (p24).
    Ehrlich LS; Krausslich HG; Wimmer E; Carter CA
    AIDS Res Hum Retroviruses; 1990 Oct; 6(10):1169-75. PubMed ID: 2123631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gag-derived proteins of HIV-1 isolates from Indian patients: cloning, expression, and purification of p24 of B- and C-subtypes.
    Gupta S; Arora K; Gupta A; Chaudhary VK
    Protein Expr Purif; 2000 Aug; 19(3):321-8. PubMed ID: 10910720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.
    Sei S; Yang QE; O'Neill D; Yoshimura K; Nagashima K; Mitsuya H
    J Virol; 2000 May; 74(10):4621-33. PubMed ID: 10775598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphogenic capabilities of human immunodeficiency virus type 1 gag and gag-pol proteins in insect cells.
    Hughes BP; Booth TF; Belyaev AS; McIlroy D; Jowett J; Roy P
    Virology; 1993 Mar; 193(1):242-55. PubMed ID: 8438569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
    Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
    Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and characterization of HIV-1 Gag p17-p24 protein].
    Li TY; Jin NY; Wang HW; Guo ZR; Fang HH; An RG; Yin Z
    Sheng Wu Gong Cheng Xue Bao; 2000 Jan; 16(1):65-8. PubMed ID: 10883279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and purification of immunologically active core protein p24 from HIV-1 fused to ricin toxin B subunit in E. coli.
    Donayre-Torres AJ; Esquivel-Soto E; Gutiérrez-Xicoténcatl Mde L; Esquivel-Guadarrama FR; Gómez-Lim MA
    Virol J; 2009 Feb; 6():17. PubMed ID: 19196485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overproduction of human immunodeficiency virus type I reverse transcriptase in Escherichia coli and purification of the enzyme.
    Saitoh A; Iwasaki H; Nakata A; Adachi A; Shinagawa H
    Microbiol Immunol; 1990; 34(6):509-21. PubMed ID: 1699113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.
    Karacostas V; Wolffe EJ; Nagashima K; Gonda MA; Moss B
    Virology; 1993 Apr; 193(2):661-71. PubMed ID: 7681610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and purification of active form of HIV-1 protease from E.coli.
    Wan M; Loh BN
    Biochem Mol Biol Int; 1995 Apr; 35(4):899-912. PubMed ID: 7627139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease.
    Erickson-Viitanen S; Manfredi J; Viitanen P; Tribe DE; Tritch R; Hutchison CA; Loeb DD; Swanstrom R
    AIDS Res Hum Retroviruses; 1989 Dec; 5(6):577-91. PubMed ID: 2692658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological characterization of the gag gene products of bovine immunodeficiency virus.
    Battles JK; Hu MY; Rasmussen L; Tobin GJ; Gonda MA
    J Virol; 1992 Dec; 66(12):6868-77. PubMed ID: 1331499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleavage of procaryotically expressed human immunodeficiency virus fusion proteins by factor Xa and application in western blot (immunoblot) assays.
    Ellinger S; Glockshuber R; Jahn G; Plückthun A
    J Clin Microbiol; 1989 May; 27(5):971-6. PubMed ID: 2501357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High variability of the gag/pol transframe region among HIV-1 isolates.
    Candotti D; Chappey C; Rosenheim M; M'Pelé P; Huraux JM; Agut H
    C R Acad Sci III; 1994 Feb; 317(2):183-9. PubMed ID: 7994608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the recombinant chimera proteins, LacZ-Env and Gag-Env, for immunological studies on HIV-1 infection.
    Morimoto M; Saitoh A; Ueba N; Nakata A; Shinagawa H
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):971-8. PubMed ID: 7506555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A peptide library expressed in yeast reveals new major epitopes from human immunodeficiency virus type 1.
    Madaule P; Gairin JE; Bénichou S; Rossier J
    FEMS Microbiol Immunol; 1991 Apr; 3(2):99-107. PubMed ID: 1713777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.
    Wagner R; Fliessbach H; Wanner G; Motz M; Niedrig M; Deby G; von Brunn A; Wolf H
    Arch Virol; 1992; 127(1-4):117-37. PubMed ID: 1456888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.